This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shubitz, L.
Right arrow Articles by Galgiani, J. N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shubitz, L.
Right arrow Articles by Galgiani, J. N

 Previous Article  |  Next Article 

Infection and Immunity, June 2002, p. 3287-3289, Vol. 70, No. 6
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.6.3287-3289.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Protection of Mice against Coccidioides immitis Intranasal Infection by Vaccination with Recombinant Antigen 2/PRA

Lisa Shubitz,1,2 Tao Peng,1,2,3 Robert Perrill,1,2 Julie Simons,1,2 Kris Orsborn,1,2,3 and John N Galgiani1,2,3,4*

Valley Fever Center for Excellence,1 Medicine and Subspecialties Program,4 Research Program, Southern Arizona Veterans Affairs Health Care System,2 Department of Medicine, University of Arizona College of Medicine, Tucson, Arizona 857233

Received 2 October 2001/ Returned for modification 26 December 2001/ Accepted 21 March 2002

Subcutaneous vaccination with recombinant antigen 2/PRA (rAg2/PRA) protected BALB/c mice against intranasal infection with Coccidioides immitis. Subcutaneously vaccinated C57BL/6 mice and intranasally vaccinated BALB/c mice were protected against larger numbers of infecting spores. Weight loss correlated with lethality, but histologic appearance did not. These studies support rAg2/PRA vaccination to prevent coccidioidomycosis.


* Corresponding author. Mailing address: Valley Fever Center for Excellence 3601 South Sixth Ave., Tucson, AZ 85723. Phone: (520) 629-4777. Fax: (520) 629-4738. E-mail: spherule{at}u.arizona.edu.

Editor: T. R. Kozel


Infection and Immunity, June 2002, p. 3287-3289, Vol. 70, No. 6
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.6.3287-3289.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Herr, R. A., Hung, C.-Y., Cole, G. T. (2007). Evaluation of Two Homologous Proline-Rich Proteins of Coccidioides posadasii as Candidate Vaccines against Coccidioidomycosis. Infect. Immun. 75: 5777-5787 [Abstract] [Full Text]  
  • Shubitz, L. F., Galgiani, J. N., Tian, Z.-Q., Zhong, Z., Timmermans, P., Katz, L. (2006). Efficacy of ambruticin analogs in a murine model of coccidioidomycosis.. Antimicrob. Agents Chemother. 50: 3467-3469 [Abstract] [Full Text]  
  • Umeyama, T., Sano, A., Kamei, K., Niimi, M., Nishimura, K., Uehara, Y. (2006). Novel Approach to Designing Primers for Identification and Distinction of the Human Pathogenic Fungi Coccidioides immitis and Coccidioides posadasii by PCR Amplification.. J. Clin. Microbiol. 44: 1859-1862 [Abstract] [Full Text]  
  • Orsborn, K. I., Shubitz, L. F., Peng, T., Kellner, E. M., Orbach, M. J., Haynes, P. A., Galgiani, J. N. (2006). Protein Expression Profiling of Coccidioides posadasii by Two-Dimensional Differential In-Gel Electrophoresis and Evaluation of a Newly Recognized Peroxisomal Matrix Protein as a Recombinant Vaccine Candidate. Infect. Immun. 74: 1865-1872 [Abstract] [Full Text]  
  • Tarcha, E. J., Basrur, V., Hung, C.-Y., Gardner, M. J., Cole, G. T. (2006). A Recombinant Aspartyl Protease of Coccidioides posadasii Induces Protection against Pulmonary Coccidioidomycosis in Mice. Infect. Immun. 74: 516-527 [Abstract] [Full Text]  
  • Awasthi, S., Awasthi, V., Magee, D. M., Coalson, J. J. (2005). Efficacy of Antigen 2/Proline-Rich Antigen cDNA-Transfected Dendritic Cells in Immunization of Mice against Coccidioides posadasii. J. Immunol. 175: 3900-3906 [Abstract] [Full Text]  
  • Cox, R. A., Magee, D. M. (2004). Coccidioidomycosis: Host Response and Vaccine Development. Clin. Microbiol. Rev. 17: 804-839 [Abstract] [Full Text]  
  • Bialek, R., Kern, J., Herrmann, T., Tijerina, R., Cecenas, L., Reischl, U., Gonzalez, G. M. (2004). PCR Assays for Identification of Coccidioides posadasii Based on the Nucleotide Sequence of the Antigen 2/Proline-Rich Antigen. J. Clin. Microbiol. 42: 778-783 [Abstract] [Full Text]  
  • Delgado, N., Xue, J., Yu, J.-J., Hung, C.-Y., Cole, G. T. (2003). A Recombinant {beta}-1,3-Glucanosyltransferase Homolog of Coccidioides posadasii Protects Mice against Coccidioidomycosis. Infect. Immun. 71: 3010-3019 [Abstract] [Full Text]  
  • Peng, T., Shubitz, L., Simons, J., Perrill, R., Orsborn, K. I., Galgiani, J. N. (2002). Localization within a Proline-Rich Antigen (Ag2/PRA) of Protective Antigenicity against Infection with Coccidioides immitis in Mice. Infect. Immun. 70: 3330-3335 [Abstract] [Full Text]